EBR SYSTEMS INC (EBR)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
EBR - EBR SYSTEMS INC
FNArena Sector : Medical Equipment & Devices
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.67
Index:
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.71
02 Oct |
OPEN $0.71 |
HIGH $0.71 |
17,199 LOW $0.71 |
0.025| TARGET | |||||
|
|||||
| OTHER COMPANIES IN THE SAME SECTOR | |||
| 4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EMV . EYE . FPH . HLA . IDX . IME . IMR . IPD . LDX . MEB . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
| Title | FY23 Forecast |
FY24 Forecast |
|---|---|---|
| EPS (cps) | - 19.1 | xxx |
| DPS (cps) | 0.0 | xxx |
| EPS Growth | N/A | xxx |
| DPS Growth | N/A | xxx |
| PE Ratio | N/A | xxx |
| Dividend Yield | 0.0% | xxx |
| Div Pay Ratio(%) | N/A | xxx |
All estimates have been converted into AUD by FNArena at present FX values.
Dividend yield today if purchased 3 years ago: N/A
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
| Title | 2021 | 2022 |
|---|---|---|
| EPS Basic | xxx | -17.7 |
| DPS All | xxx | 0.0 |
| Sales/Revenue | xxx | - |
| Book Value Per Share | xxx | 23.9 |
| Net Operating Cash Flow | xxx | -43.2 M |
| Net Profit Margin | xxx | - |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2021 | 2022 |
|---|---|---|
| Return on Capital Employed | xxx | -56.42 % |
| Return on Invested Capital | xxx | -46.87 % |
| Return on Assets | xxx | -42.77 % |
| Return on Equity | xxx | -56.42 % |
| Return on Total Capital | xxx | -46.58 % |
| Free Cash Flow ex dividends | xxx | -44.3 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2021 | 2022 |
|---|---|---|
| Short-Term Debt | xxx | 0 M |
| Long Term Debt | xxx | 31 M |
| Total Debt | xxx | 32 M |
| Goodwill - Gross | xxx | - |
| Cash & Equivalents - Generic | xxx | 94 M |
| Price To Book Value | xxx | 1.92 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2021 | 2022 |
|---|---|---|
| Capex | xxx | 1.1 M |
| Capex % of Sales | xxx | - |
| Cost of Goods Sold | xxx | 1 M |
| Selling, General & Admin. Exp & Other | xxx | 47 M |
| Research & Development | xxx | 19 M |
| Investments - Total | xxx | 1 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EBR STOCK CHART
FNArena News on EBR
| 1 |
Australian Broker Call *Extra* Edition – Sep 08, 2023Sep 08 2023 - Daily Market Reports |
| 2 |
FNArena Corporate Results Monitor – 30-08-2023Aug 30 2023 - Australia |
| 3 |
Australian Broker Call *Extra* Edition – Jul 06, 2023Jul 06 2023 - Daily Market Reports |
| 4 |
Weekly Ratings, Targets, Forecast Changes – 26-05-23May 29 2023 - Weekly Reports |
| 5 |
Australian Broker Call *Extra* Edition – May 25, 2023May 25 2023 - Daily Market Reports |
Latest Medical Equipment & Devices News
| 1 |
Dr Boreham’s Crucible: PainchekSep 11 2023 - Small Caps |
| 2 |
Margins Signal Integral Diagnostics RecoverySep 07 2023 - Australia |
| 3 |
ResMed: Finding A Base?Aug 15 2023 - Technicals |
| 4 |
August Turns ResMed Into Nigel NoMatesAug 09 2023 - Australia |
| 5 |
Dr Boreham’s Crucible: Lumos DiagnosticsJun 19 2023 - Small Caps |
| 6 |
Fisher & Paykel Healthcare: Lower Margin, Higher SpendingMay 30 2023 - Australia |
| 7 |
Dr Boreham’s Crucible: ImpedimedMay 08 2023 - Small Caps |
| 8 |
Treasure Chest: ResMed’s Benevolent MonopolyMay 01 2023 - Treasure Chest |
| 9 |
Dr Boreham’s Crucible: Volpara Health TechnologiesApr 26 2023 - Small Caps |
| 10 |
Dr Boreham’s Crucible: SDIMar 16 2023 - Small Caps |
